NanoViricides Inc.

NNVC XASE • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

34M

Short interest (Jul 15)

3.2%

Net Short (Jul 27 ): 0.1%

Borrow Fee

2.31%

↑ 24.3%

Available Shares

↑ 61.3%

Price Chart

Company Overview

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Company Info

Exchange: XASE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001379006

Asset Type: CS

Market Data

Market Cap: $34,014,567

Employees: 7

Status: Active

Short Interest

Current Borrow Fee 2.31%

Range: 2.31% - 2.31%

Available Shares 2M

Range: 1.6M - 1.9M

Recent Changes

Fee Change: ↑ 4.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime